fusidic acid has been researched along with niraparib in 1 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (niraparib) | Trials (niraparib) | Recent Studies (post-2010) (niraparib) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 212 | 46 | 209 |
| Protein | Taxonomy | fusidic acid (IC50) | niraparib (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase tankyrase-1 | Homo sapiens (human) | 1.7564 | |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.0278 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0021 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0021 | |
| Protein mono-ADP-ribosyltransferase PARP14 | Homo sapiens (human) | 1.7378 | |
| Protein mono-ADP-ribosyltransferase PARP10 | Homo sapiens (human) | 2.6153 | |
| Protein mono-ADP-ribosyltransferase PARP12 | Homo sapiens (human) | 0.4367 | |
| Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | 5.1293 | |
| Poly [ADP-ribose] polymerase 2 | Homo sapiens (human) | 0.2306 | |
| Protein mono-ADP-ribosyltransferase PARP4 | Homo sapiens (human) | 0.4076 | |
| Protein mono-ADP-ribosyltransferase PARP3 | Homo sapiens (human) | 0.3797 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, F; Damerval, M; Hugues, M; Mayer, J; Omrani, S; Roux, MF | 1 |
1 other study(ies) available for fusidic acid and niraparib
| Article | Year |
|---|---|
Pancytopenia in a patient treated with fusidic acid and niraparib: a case report.
Topics: Anti-Bacterial Agents; Fusidic Acid; Humans; Indazoles; Pancytopenia | 2023 |